Physician profile
David Webb
NPI 1083685259
$9,994.76
in general payments reported to CMS, 2019-2025
25 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $295 · 2020: $8,430 · 2021: $249 · 2022: $177 · 2023: $293 · 2024: $339 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $843.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,300.00 | 2020 | |
| Abbvie INC. | $335.12 | 2019-2024 | |
| Astellas Pharma US INC | $289.88 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $225.34 | 2021-2025 | |
| Exeltis, USA INC. | $104.87 | 2023-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $79.19 | 2019-2023 | |
| Aspira Women'S Health INC | $74.86 | 2021 | |
| Biogen, INC. | $66.39 | 2024 | Zurzuvae |
| Pfizer INC. | $61.10 | 2019-2025 | |
| Coopersurgical, INC. | $59.04 | 2019-2024 | Advincula Delineator Uterine Manipulator, Fisherbrand Disposable Liquid Infant Heel Warmer |
| Organon LLC | $48.56 | 2022-2025 | Nexplanon |
| Lupin INC. | $37.31 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $36.38 | 2019 | |
| Convatec INC. | $34.91 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $33.80 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $32.77 | 2019-2020 | |
| Daiichi Sankyo INC. | $30.86 | 2019-2024 | Injectafer |
| Ardelyx, INC. | $27.25 | 2024 | Ibsrela |
| Avion Pharmaceuticals | $26.62 | 2020-2022 | |
| Teleflex LLC | $18.13 | 2024 | Deknatel |
| Amgen INC. | $15.94 | 2025 | Evenity |
| Therapeuticsmd, INC. | $15.09 | 2021 | |
| Millicent US INC | $14.98 | 2025 | Intrarosa, Femring |
| Cumberland Pharmaceuticals, INC. | $13.52 | 2021 | |
| Merck Sharp & Dohme LLC | $12.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.